Interferon in multiple myeloma--does it pay?
Kedar, I.; Segal, A.
Israel Journal of Medical Sciences 31(10): 635-637
1995
ISSN/ISBN: 0021-2180 PMID: 7591691 Document Number: 445052
Document emailed within 1 workday
Related Documents
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56
Piatkowska-Jakubas, B.; Skotnicki, A.B.; Blicharski, J. 1988: Possibility of using interferon in the treatment of multiple myeloma Przeglad Lekarski 45(10): 747-750
Yoshida, M.; Ohta, M.; Muroi, K.; Takeda, K.; Kitagawa, S.; Tsuboyama, A.; Sakamoto, S.; Miura, Y.; Mutoh, Y. 1984: Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1394-1398
Cooper, M.R. 1991: A review of the clinical studies of alpha-interferon in the management of multiple myeloma Seminars in Oncology 18(5 Suppl 7: 18-29
Liberati, A.M.; Cinieri, S.; Senatore, M.G.; Portuesi, M.G.; De Angelis, V.; Di Clemente, F.; Schippa, M.; Ferrajoli, A.; Arzano, S.; Berruto, P. 1990: Phase I-Ii trial on natural beta interferon in chemoresistant and relapsing multiple myeloma Haematologica 75(5): 436-442
Pisa, P.; Stenke, L.; Bernell, P.; Hansson, M.; Hast, R. 1990: Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients Anticancer Research 10(3): 817-820
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Palumbo, A.P.; Garino, A.L.; Frieri, R.; Gallone, G.; Boccadoro, M.; Pileri, A. 1990: Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy Haematologica 75(6): 576-578
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hiebel, J.; Boyd, M.A.; Shepp, M.A.; Dorsk, B.M.; Bonnem, E. 1986: Phase Ii study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase Cancer Treatment Reports 70(11): 1251-1254
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Tomita, S.; Okamoto, S. 2007: Role of interferon for the treatment of myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2285-2290
Demina, E.A.; Votiakova, O.M. 1996: Alpha-interferon in present-day treatment of myeloma Gematologiia i Transfuziologiia 41(2): 32-36
Liu, P.; Oken, M.; Van Ness, B. 1999: Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis Leukemia 13(3): 473-480
Wasastjerna, C. 1974: Multiple myeloma Duodecim; Laaketieteellinen Aikakauskirja 90(10): 751-764